Cytokines are pleiotropic molecules with important roles in inflammatory responses. Pro-inflammatory cytokines and neuroinflammation are important not only in inflammatory responses but also in neurogenesis and neuroprotection. Sustained stress and the subsequent release of pro-inflammatory cytokines lead to chronic neuroinflammation, which contributes to depression. Hippocampal glucocorticoid receptors (GRs) and the associated hypothalamus-pituitary-adrenal (HPA) axis have close interactions with pro-inflammatory cytokines and neuroinflammation. Elevated pro-inflammatory cytokine levels and GR functional resistance are among the most widely investigated factors in the pathophysiology of depression. These two major components create a vicious cycle. In brief, chronic neuroinflammation inhibits GR function, which in turn exacerbates pro-inflammatory cytokine activity and aggravates chronic neuroinflammation. On the other hand, neuroinflammation causes an imbalance between oxidative stress and the anti-oxidant system, which is also associated with depression. Although current evidence strongly suggests that cytokines and GRs have important roles in depression, they are essential components of a whole system of inflammatory and endocrine interactions, rather than playing independent parts. Despite the evidence that a dysfunctional immune and endocrine system contributes to the pathophysiology of depression, much research remains to be undertaken to clarify the cause and effect relationship between depression and neuroinflammation.
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Introduction
Major depressive disorder (MDD) is one of the most common mental disorders, affecting approximately 1 in 6 individuals in the United States during their lifetime (Kessler et al., 2005) . MDD is also expected to be the second leading contributor to overall disease burden by 2030 (Mathers and Loncar, 2006) . Given its increasing clinical and socioeconomic impacts, numerous studies have investigated the etiopathology of MDD, with the most widely investigated biochemical markers being the monoamine neurotransmitters (Hirschfeld, 2000) . However, although monoamines may have the largest role in MDD, evidence suggests that considering monoamines alone is unlikely to lead to the development of novel therapeutics. Rather, more complex neural mechanisms are thought to be involved in depression (Kim et al., 2002; Myint et al., 2007) . In this manuscript, we review the complex roles of cytokines and glucocorticoid receptors (GRs) in MDD.
Cytokines and neuroinflammation

Cytokines
Cytokines are large proteins (15-25 kDa) that are mainly released from immune cells such as monocytes, macrophages and lymphocytes, in addition to microglia and astrocytes. Cytokines are activated during situations in which inflammation, infection and/or immunological alterations occur and are mainly involved in the repair of damaged tissues and the restoration of homeostasis (Nathan, 2002; Woodroofe, 1995) . Cytokines mediate signals between immune cells and are generally divided into pro-inflammatory and anti-inflammatory cytokines, which facilitate and inhibit inflammatory responses, respectively.
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